KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics, Inc. (PVLA) Non-Current Assets (2016 - 2022)

Palvella Therapeutics (PVLA) has disclosed Non-Current Assets for 11 consecutive years, with $287000.0 as the latest value for Q3 2023.

  • On a quarterly basis, Non-Current Assets fell 98.61% to $287000.0 in Q3 2023 year-over-year; TTM through Dec 2023 was $43.1 million, a 52.85% decrease, with the full-year FY2022 number at $22.1 million, down 14.92% from a year prior.
  • Non-Current Assets was $287000.0 for Q3 2023 at Palvella Therapeutics, down from $21.1 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $29.3 million in Q4 2020 to a low of -$111.5 million in Q2 2019.
  • A 5-year average of $15.7 million and a median of $25.4 million in 2020 define the central range for Non-Current Assets.
  • Biggest YoY gain for Non-Current Assets was 337.72% in 2019; the steepest drop was 2154.22% in 2019.
  • Palvella Therapeutics' Non-Current Assets stood at $26.1 million in 2019, then increased by 12.29% to $29.3 million in 2020, then decreased by 11.45% to $25.9 million in 2021, then dropped by 14.92% to $22.1 million in 2022, then tumbled by 98.7% to $287000.0 in 2023.
  • Per Business Quant, the three most recent readings for PVLA's Non-Current Assets are $287000.0 (Q3 2023), $21.1 million (Q2 2023), and $21.8 million (Q1 2023).